MIKEL
GARCÍA PUGA
![Foto de MIKEL](/img/nophoto.png)
![Foto de Instituto de Salud Carlos III](/img/noimage_org.png)
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (4)
2022
-
Senescence plays a role in myotonic dystrophy type 1
JCI insight, Vol. 7, Núm. 19
-
Targeting Myotonic Dystrophy Type 1 with Metformin
International Journal of Molecular Sciences, Vol. 23, Núm. 5
2020
-
Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study
Annals of Clinical and Translational Neurology, Vol. 7, Núm. 1, pp. 126-131
2016
-
Cancer risk in DM1 is sex-related and linked to miRNA-200/141 downregulation
Neurology, Vol. 87, Núm. 12, pp. 1250-1257